
It’s been a long time coming. Nearly a decade has passed since ATL took a serious run at advancing the medical art of breast cancer diagnosis. The company, long-since absorbed by Philips Healthcare, developed a novel algorithm designed for its Ultramark 9 HDI, later adapted for its HDI 3000 and 5000.























